The Ibex advances positions and is at the edge of 7,000 points (+ 1,13%. 6,934 points) harangued by good sentiment from Asia and new news about coronavirus vaccines. Some regions of Japan have resumed close-to-normal commercial activity, and hopes of economic recovery have encouraged investors.
Japan I have lifted its state of emergency as far as the Prime Minister, Shinzo Abe called a new lifestyle on Monday, with the widespread use of face masks and protectors.
“As is customary in the financial markets these days, even the slightest positive news on the Covid-19 front triggers a bullish response,” says Jeffrey Halley, an Oanda expert.
Today Wall Street recovers normality after the holiday of the last day, like the United Kingdom. As for the Ibex, after closing this Monday with increases of more than 2% and clearly above 6,800 points, is trying the 7,000 point resistance. Little by little, and without making noise, it is already glued to this level, which is where the straight resistance that joins the declining maximums of April and May passes. And above, and of greater draft, we have the resistances of 7,128 and the April highs at 7,210 points“the analysts of Bolsamanía explain.
The latest encouraging macro data has also helped cheer up the market. Last week it was the PMIs and this Monday the German IFO. Investors will be pending consumer confidence in the US. Also, news about possible vaccines is always well received. The last one has to do with the American company Novavax, which is about to begin its first human studies of its experimental coronavirus vaccine, which has also helped cheer up the bags.
Novavax, based in Maryland, is one of the biotech companies competing to develop a vaccine against SARS-CoV-2, the virus that causes Covid-19. Two other companies, Modern and BioNTech (in association with Pfizer) Clinical trials have already started.